1 Motomura S, Motoj T, Takanashi M, Wang YH, Shiozaki H, Sugawara I, et al.Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides[J].Blood, 1998;91(9):3163-71 2 魏虎来, 姚小健, 李宇宁, 王蓓, 赵怀顺, 白德成, 等.三氧化二砷抑制K562/ADM 细胞P-糖蛋白表达并提高化疗药物的敏感性[J].中华血液学杂志, 2003;24(1):28-31 3 Wei HL, Su HX, Yao XJ.Biological feature of human T-activated killer cells[J].Chin J Cancer Res, 1999;11(2):111-4 4 李尹雄.核酸的分离与纯化[A].见:卢圣栋, 主编.现代分子生物学实验技术[M].第2 版.北京:中国协和医科大学出版社, 1999:107-8 5 Boffa LC, Scarfi S, Mariani MR, Damonte G, Allfrey VG, Benatti U, et al.Dihydrotestoterone as a selective cellular nuclear location vector for anti-gene peptide nucleic acid in prostatic carcinoma cells[J].Cancer Res, 2000;60(8):2258-62 6 Aggarwal S, Gupta S.Increased apoptosis of T cell subsets in aging humans:altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax[J].J Immunol, 1998;160(4):1627-37 7 Djebaili M, De Bock F, Baille V.Bockaert J, Rondouin G. Implication of p53 and caspase-3 in kainic acid but not in Nmethyl-D-aspartic acid-induced apoptosis in organotypic hippocampal mouse cultures[J].Neurosci Lett, 2002;327(1):1-4 8 Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, et al. Use of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL):Ⅰ.As2O3 exerts dose-dependent dual effects on APL cells[J].Blood, 1997;89(9):3345-53 9 Lehmann S, Bengtzen S, Paul A, Christensson B, Paul C.Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia:studies of cytotoxity, apoptosis and the pattern of resistance[J].Eur J Haematol, 2001;66(6):357-64 10 邹俊晖, 潘祥林, 冯长伟, 郭娟娟.三氧化二砷对K562 及其多药耐药细胞系K562/A02 细胞的诱导凋亡研究[J].中华血液学杂志, 2002;23(1):37-8 |